Personalized Epigenetics: Edition 2

ยท Elsevier
แžŸแŸ€แžœแž—แŸ…โ€‹แžขแŸแžกแžทแž…แžแŸ’แžšแžผแž“แžทแž…
700
แž‘แŸ†แž–แŸแžš
แž˜แžถแž“แžŸแžทแž‘แŸ’แž’แžท
แž€แžถแžšแžœแžถแž™แžแž˜แŸ’แž›แŸƒ แž“แžทแž„แž˜แžแžทแžœแžถแž™แžแž˜แŸ’แž›แŸƒแž˜แžทแž“แžแŸ’แžšแžผแžœแž”แžถแž“แž•แŸ’แž‘แŸ€แž„แž•แŸ’แž‘แžถแžแŸ‹แž‘แŸ แžŸแŸ’แžœแŸ‚แž„แž™แž›แŸ‹แž”แž“แŸ’แžแŸ‚แž˜

แžขแŸ†แž–แžธแžŸแŸ€แžœแž—แŸ…โ€‹แžขแŸแžกแžทแž…แžแŸ’แžšแžผแž“แžทแž€แž“แŸแŸ‡

Personalized Epigenetics, Second Edition discusses the core translatability of epigenetics to health management of individuals who have unique variations in their epigenetic signatures that can guide both disorder and disease prevention and therapy. Fully updated and revised, this new edition details inter-individual variability in the major epigenetic process in humans consisting of DNA methylation, histone modifications, noncoding RNA, and the diagnostic, prognostic, and therapeutic potential of the field. It also reviews the impact of the environment on epigenetic variations among individuals and the role of pharmacology and drug development in personalized epigenetics.Most importantly, the text covers personalized epigenetics from a disease-oriented perspective, presenting chapters that provide advances in widespread disorders or diseases, including diabetes, cancer, autoimmune disorders, obesity, cardiovascular diseases, neurological disorders, and pain management. - Includes new chapters on topics such as the limitations of personalized epigenetic variation comparisons; personalized epigenetics technologies; epigenetics of personalized nanomedicine; personalized epigenetic management of diabetes; epigenetics and chemoresistance; and personalized epigenetics and neurological disorders - Covers key methodological processes that are important in personalized medicine - Offers disease research case studies to provide in-depth discussion of examples of recent epigenetic research on a disease area - Features topics such as forensic epigenetics, epigenetics of personalized toxicity, limitations of epigenetic variation comparisons, and nanomedicine and nutrigenomics as applied to personalized epigenetics

แžขแŸ†แž–แžธโ€‹แžขแŸ’แž“แž€แž“แžทแž–แž“แŸ’แž’

Dr. Tollefsbol is a Professor of Biology and a Senior Scientist in the Center for Aging, Comprehensive Cancer Center, Nutrition Obesity Research Center, and the Comprehensive Diabetes Center at the University of Alabama at Birmingham (UAB). He is Director of the UAB Cell Senescence Culture Facility which he established in 1999 and a Steering Committee Member of the UAB Center for Aging. Dr. Tollefsbol trained as a Postdoctoral Fellow and Assistant Research Professor with members of the National Academy of Science at Duke University and the University of North Carolina. He earned doctorates in molecular biology and osteopathic medicine from the University of North Texas Health Sciences Center and his bachelorโ€™s degree in biology from the University of Houston. He has received prior funding from the NIA, NCI, NHLBI, NIMH and other federal institutes as well as the Glenn Foundation for Medical Research, Susan G. Komen for the Cure, the American Federation for Aging Research (AFAR), and the American Institute for Cancer Research (AICR) among many other sources.

แžœแžถแž™แžแž˜แŸ’แž›แŸƒแžŸแŸ€แžœแž—แŸ…โ€‹แžขแŸแžกแžทแž…แžแŸ’แžšแžผแž“แžทแž€แž“แŸแŸ‡

แž”แŸ’แžšแžถแž”แŸ‹แž™แžพแž„แžขแŸ†แž–แžธแž€แžถแžšแž™แž›แŸ‹แžƒแžพแž‰แžšแž”แžŸแŸ‹แžขแŸ’แž“แž€แŸ”

แžขแžถแž“โ€‹แž–แŸแžแŸŒแž˜แžถแž“

แž‘แžผแžšแžŸแž–แŸ’แž‘แž†แŸ’แž›แžถแžแžœแŸƒ แž“แžทแž„โ€‹แžแŸแž”แŸ’แž›แŸแž
แžŠแŸ†แžกแžพแž„แž€แž˜แŸ’แž˜แžœแžทแž’แžธ Google Play Books แžŸแž˜แŸ’แžšแžถแž”แŸ‹ Android แž“แžทแž„ iPad/iPhone แŸ” แžœแžถโ€‹แž’แŸ’แžœแžพแžŸแž˜แž€แžถแž›แž€แž˜แŸ’แž˜โ€‹แžŠแŸ„แž™แžŸแŸ’แžœแŸแž™แž”แŸ’แžšแžœแžแŸ’แžแžทแž‡แžถแž˜แžฝแž™โ€‹แž‚แžŽแž“แžธโ€‹แžšแž”แžŸแŸ‹แžขแŸ’แž“แž€โ€‹ แž“แžทแž„โ€‹แžขแž“แžปแž‰แŸ’แž‰แžถแžแžฑแŸ’แž™โ€‹แžขแŸ’แž“แž€แžขแžถแž“แž–แŸแž›โ€‹แž˜แžถแž“แžขแŸŠแžธแž“แž’แžบแžŽแžทแž แžฌแž‚แŸ’แž˜แžถแž“โ€‹แžขแŸŠแžธแž“แž’แžบแžŽแžทแžโ€‹แž“แŸ…แž‚แŸ’แžšแž”แŸ‹แž‘แžธแž€แž“แŸ’แž›แŸ‚แž„แŸ”
แž€แžปแŸ†แž–แŸ’แž™แžผแž‘แŸแžšโ€‹แž™แžฝแžšแžŠแŸƒ แž“แžทแž„แž€แžปแŸ†แž–แŸ’แž™แžผแž‘แŸแžš
แžขแŸ’แž“แž€แžขแžถแž…แžŸแŸ’แžŠแžถแž”แŸ‹แžŸแŸ€แžœแž—แŸ…แž‡แžถแžŸแŸ†แžกแŸแž„แžŠแŸ‚แž›แž”แžถแž“แž‘แžทแž‰แž“แŸ…แž€แŸ’แž“แžปแž„ Google Play แžŠแŸ„แž™แž”แŸ’แžšแžพแž€แž˜แŸ’แž˜แžœแžทแž’แžธแžšแžปแž€แžšแž€แžแžถแž˜แžขแŸŠแžธแž“แž’แžบแžŽแžทแžแž€แŸ’แž“แžปแž„แž€แžปแŸ†แž–แŸ’แž™แžผแž‘แŸแžšแžšแž”แžŸแŸ‹แžขแŸ’แž“แž€แŸ”
eReaders แž“แžทแž„โ€‹แžงแž”แž€แžšแžŽแŸโ€‹แž•แŸ’แžŸแŸแž„โ€‹แž‘แŸ€แž
แžŠแžพแž˜แŸ’แž”แžธแžขแžถแž“แž“แŸ…แž›แžพโ€‹แžงแž”แž€แžšแžŽแŸ e-ink แžŠแžผแž…แž‡แžถโ€‹แžงแž”แž€แžšแžŽแŸแžขแžถแž“โ€‹แžŸแŸ€แžœแž—แŸ…แžขแŸแžกแžทแž…แžแŸ’แžšแžผแž“แžทแž€ Kobo แžขแŸ’แž“แž€แž“แžนแž„แžแŸ’แžšแžผแžœโ€‹แž‘แžถแž‰แž™แž€โ€‹แžฏแž€แžŸแžถแžš แž แžพแž™โ€‹แž•แŸ’แž‘แŸแžšแžœแžถแž‘แŸ…โ€‹แžงแž”แž€แžšแžŽแŸโ€‹แžšแž”แžŸแŸ‹แžขแŸ’แž“แž€แŸ” แžŸแžผแž˜แžขแž“แžปแžœแžแŸ’แžแžแžถแž˜โ€‹แž€แžถแžšแžŽแŸ‚แž“แžถแŸ†แž›แž˜แŸ’แžขแžทแžแžšแž”แžŸแŸ‹แž˜แž‡แŸ’แžˆแž˜แžŽแŸ’แžŒแž›แž‡แŸ†แž“แžฝแž™ แžŠแžพแž˜แŸ’แž”แžธแž•แŸ’แž‘แŸแžšแžฏแž€แžŸแžถแžšโ€‹แž‘แŸ…แžงแž”แž€แžšแžŽแŸแžขแžถแž“แžŸแŸ€แžœแž—แŸ…โ€‹แžขแŸแžกแžทแž…แžแŸ’แžšแžผแž“แžทแž€แžŠแŸ‚แž›แžŸแŸ’แž‚แžถแž›แŸ‹แŸ”